| Literature DB >> 33646354 |
Liliane Poleto1,2, Letícia Osório da Rosa1, Roselei Claudete Fontana1, Eliseu Rodrigues3, Édina Poletto4, Guilherme Baldo4, Suelen Paesi2, Ceci Sales-Campos5, Marli Camassola6.
Abstract
The antimicrobial activity of the metabolites produced by Fusarium oxysporum PR-33 in submerged culture was evaluated against Gram-positive and Gram-negative bacteria and yeasts. Metabolites were determined by HPLC-DAD-MS/MS. An extract was obtained following the removal of mycelium by centrifugation and lyophilisation of the supernatant. The compounds in this extract demonstrated broad-spectrum antimicrobial action, with rates of inhibition between 60 and 80%, depending on the species and extract tested. The major compounds of the extracts were identified as fusarinolic acid and its isomer [56.9% flask extract (FE)] and 59.2% bioreactor extract (BE), dehydrofusaric acid (35.7% FE and 31.6% BE), and fusaric acid (6.5% FE and 1.1% BE). Fusaric acid has been shown to be responsible for antimicrobial activity. The cytotoxicity of the extracts was evaluated in culture of HEK-293 and SH-SY5Y animal cells and toxicity of these extracts was verified even in the lowest tested concentrations. Therefore, our results indicate that the compounds identified exhibit potential as antimicrobial agents.Entities:
Keywords: Antibiotics; Antimicrobial agents; Antimicrobial resistance; Biopharmaceuticals; Screening test
Mesh:
Substances:
Year: 2021 PMID: 33646354 DOI: 10.1007/s00449-021-02538-2
Source DB: PubMed Journal: Bioprocess Biosyst Eng ISSN: 1615-7591 Impact factor: 3.210